LONDON--(BUSINESS WIRE)--The structural heart disease treatment devices market is poised to grow by USD 5.61 billion during 2020-2024, progressing at a CAGR of over 10% during the forecast period. Request free sample pages
Read the 165-page report with TOC on "Structural Heart Disease Treatment Devices Market Analysis Report by End-user (hospitals and clinics and ASCs), Product (replacement devices and repair devices), and Geographic Landscape (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2020-2024".
The market is driven by the increase in structural heart diseases. In addition, the technological innovations in structural heart disease treatment are anticipated to boost the growth of the structural heart disease treatment devices market.
The prevalence of structural heart diseases such as aortic stenosis, heart valve disease, valvular stenosis, and congenital heart defects is increasing around the globe. According to the NIH, in 2019, about 10% of the population aged 75 and above were found with degenerative abnormalities associated with severe aortic stenosis and mitral and tricuspid regurgitation. The prevalence of heart valve diseases such as CHD is also increasing among the elderly population. This in turn, will increase the demand for structural heart disease treatment devices and thus drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Structural Heart Disease Treatment Devices Companies:
Abbott Laboratories is headquartered in the US and operates the business under various segments such as Established Pharmaceuticals, Nutritionals, Diagnostics, and Cardiovascular and Neuromodulation. The company offers AMPLATZER PFO Occluder, MitraClip, and Trifecta GT aortic valve.
Becton, Dickinson and Co.
Becton, Dickinson and Co. is headquartered in the US and offers products through the following business units: Medical, Life Sciences, and Interventional. The company offers TRUE Dilatation balloon valvuloplasty catheters and TRUE Flow valvuloplasty perfusion catheter.
Boston Scientific Corp.
Boston Scientific Corp. is headquartered in the US and operates under various business segments, namely MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers WATCHMAN and LOTUS Edge Aortic Valve System.
Braile Biomédica is headquartered in Brazil and offers products through the following business segments: Biological, Cardiovascular, Electromedicals, Endovascular, Oncology, and Transcatheter. The company offers Malleable Valve Annuloplasty Ring and Organic Valve Prosthesis Porcine.
CryoLife Inc. is headquartered in the US and offers products through the following two business segments: Medical devices and Preservation services. The company offers On-X Heart Valve and CryoValve SG Pulmonary Human Heart Valves.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Structural Heart Disease Treatment Devices Market End-user Outlook (Revenue, USD bn, 2020-2024)
- Hospitals and clinics
Structural Heart Disease Treatment Devices Market Product Outlook (Revenue, USD bn, 2020-2024)
- Replacement devices
- Repair devices
Structural Heart Disease Treatment Devices Market Geographic Landscape Outlook (Revenue, USD bn, 2020-2024)
- North America
- Key leading countries
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.